{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T05:32:37Z","timestamp":1725514357837},"publisher-location":"Boston, MA","reference-count":81,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9780387715179"},{"type":"electronic","value":"9780387715186"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008]]},"DOI":"10.1007\/978-0-387-71518-6_11","type":"book-chapter","created":{"date-parts":[[2008,5,23]],"date-time":"2008-05-23T15:43:29Z","timestamp":1211557409000},"page":"121-127","source":"Crossref","is-referenced-by-count":0,"title":["Basement Membrane Derived Inhibitors of Angiogenesis"],"prefix":"10.1007","author":[{"given":"Michael B.","family":"Duncan","sequence":"first","affiliation":[]},{"given":"Raghu","family":"Kalluri","sequence":"additional","affiliation":[]}],"member":"297","reference":[{"issue":"6","key":"11_CR1","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/nrc1094","volume":"3","author":"R Kalluri","year":"2003","unstructured":"Kalluri R. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 2003;3(6):422\u201333.","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"11_CR2","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1161\/01.RES.0000191547.64391.e3","volume":"97","author":"GE Davis","year":"2005","unstructured":"Davis GE, Senger DR. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 2005;97(11):1093\u2013107.","journal-title":"Circ Res"},{"issue":"5430","key":"11_CR3","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1126\/science.285.5430.1028","volume":"285","author":"FG Giancotti","year":"1999","unstructured":"Giancotti FG, Ruoslahti E. Integrin signaling. Science 1999;285 (5430):1028\u201332.","journal-title":"Science"},{"issue":"5","key":"11_CR4","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1083\/jcb.200103111","volume":"154","author":"J Xu","year":"2001","unstructured":"Xu J, Rodriguez D, Petitclerc E, et al. Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. J Cell Biol 2001;154(5):1069\u201379.","journal-title":"J Cell Biol"},{"issue":"3","key":"11_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0966-3274(97)80035-4","volume":"5","author":"JA Madri","year":"1997","unstructured":"Madri JA. Extracellular matrix modulation of vascular cell behaviour. Transpl Immunol 1997;5(3):179\u201383.","journal-title":"Transpl Immunol"},{"issue":"9","key":"11_CR6","first-page":"2520","volume":"60","author":"PC Colorado","year":"2000","unstructured":"Colorado PC, Torre A, Kamphaus G, et al. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res 2000;60(9):2520\u20136.","journal-title":"Cancer Res"},{"issue":"10","key":"11_CR7","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1172\/JCI24813","volume":"115","author":"A Sudhakar","year":"2005","unstructured":"Sudhakar A, Nyberg P, Keshamouni VG, et al. Human alpha1 type IV collagen NC1 domain exhibits distinct antiangiogenic activity mediated by alpha1beta1 integrin. J Clin Invest 2005;115(10):2801\u201310.","journal-title":"J Clin Invest"},{"issue":"9","key":"11_CR8","doi-asserted-by":"publisher","first-page":"6020","DOI":"10.1074\/jbc.M509134200","volume":"281","author":"B Wang","year":"2006","unstructured":"Wang B, Sun J, Kitamoto S, et al. Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J Biol Chem 2006;281(9):6020\u20139.","journal-title":"J Biol Chem"},{"issue":"2","key":"11_CR9","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1074\/jbc.275.2.1209","volume":"275","author":"GD Kamphaus","year":"2000","unstructured":"Kamphaus GD, Colorado PC, Panka DJ, et al. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 2000;275(2):1209\u201315.","journal-title":"J Biol Chem"},{"issue":"10","key":"11_CR10","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1158\/0008-5472.CAN-04-3536","volume":"65","author":"C Magnon","year":"2005","unstructured":"Magnon C, Galaup A, Mullan B, et al. Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with alphavbeta3 and alphavbeta5 integrins. Cancer Res 2005;65(10):4353\u201361.","journal-title":"Cancer Res"},{"issue":"39","key":"11_CR11","doi-asserted-by":"publisher","first-page":"37632","DOI":"10.1074\/jbc.M307339200","volume":"278","author":"DJ Panka","year":"2003","unstructured":"Panka DJ, Mier JW. Canstatin inhibits Akt activation and induces Fas-dependent apoptosis in endothelial cells. J Biol Chem 2003;278(39):37632\u20136.","journal-title":"J Biol Chem"},{"issue":"11","key":"11_CR12","doi-asserted-by":"publisher","first-page":"8051","DOI":"10.1074\/jbc.275.11.8051","volume":"275","author":"E Petitclerc","year":"2000","unstructured":"Petitclerc E, Boutaud A, Prestayko A, et al. New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. J Biol Chem 2000;275(11):8051\u201361.","journal-title":"J Biol Chem"},{"issue":"2","key":"11_CR13","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.bbrc.2004.04.038","volume":"318","author":"GA He","year":"2004","unstructured":"He GA, Luo JX, Zhang TY, Hu ZS, Wang FY. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells. Biochem Biophys Res Commun 2004;318(2):354\u201360.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"11_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.bbrc.2003.11.003","volume":"312","author":"GA He","year":"2003","unstructured":"He GA, Luo JX, Zhang TY, Wang FY, Li RF. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth. Biochem Biophys Res Commun 2003;312(3):801\u20135.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"11_CR15","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0002-9440(10)62310-3","volume":"166","author":"JM Roth","year":"2005","unstructured":"Roth JM, Akalu A, Zelmanovich A, et al. Recombinant alpha2(IV) NC1 domain inhibits tumor cell-extracellular matrix interactions, induces cellular senescence, and inhibits tumor growth in vivo. Am J Pathol 2005;166(3):901\u201311.","journal-title":"Am J Pathol"},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev.biochem.67.1.609","volume":"67","author":"RV Iozzo","year":"1998","unstructured":"Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998;67:609\u201352.","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"11_CR17","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1172\/JCI200113738","volume":"108","author":"RV Iozzo","year":"2001","unstructured":"Iozzo RV, San Antonio JD. Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J Clin Invest 2001; 108(3):349\u201355.","journal-title":"J Clin Invest"},{"issue":"14","key":"11_CR18","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1158\/0008-5472.CAN-04-0810","volume":"64","author":"Z Zhou","year":"2004","unstructured":"Zhou Z, Wang J, Cao R, et al. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Res 2004;64(14):4699\u2013702.","journal-title":"Cancer Res"},{"issue":"6","key":"11_CR19","doi-asserted-by":"publisher","first-page":"4238","DOI":"10.1074\/jbc.M210445200","volume":"278","author":"M Mongiat","year":"2003","unstructured":"Mongiat M, Sweeney SM, San Antonio JD, Fu J, Iozzo RV. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J Biol Chem 2003;278(6):4238\u201349.","journal-title":"J Biol Chem"},{"issue":"1","key":"11_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1083\/jcb.200401150","volume":"166","author":"G Bix","year":"2004","unstructured":"Bix G, Fu J, Gonzalez EM, et al. Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin. J Cell Biol 2004;166(1):97\u2013109.","journal-title":"J Cell Biol"},{"issue":"22","key":"11_CR21","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1093\/jnci\/djj441","volume":"98","author":"G Bix","year":"2006","unstructured":"Bix G, Castello R, Burrows M, et al. Endorepellin in vivo: targeting the tumor vasculature and retarding cancer growth and metabolism. J Natl Cancer Inst 2006;98(22):1634\u201346.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"11_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0009-8981(96)06395-4","volume":"255","author":"O Oda","year":"1996","unstructured":"Oda O, Shinzato T, Ohbayashi K, et al. Purification and characterization of perlecan fragment in urine of end-stage renal failure patients. Clin Chim Acta 1996;255(2):119\u201332.","journal-title":"Clin Chim Acta"},{"issue":"8","key":"11_CR23","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/pmic.200300455","volume":"3","author":"F Vuadens","year":"2003","unstructured":"Vuadens F, Benay C, Crettaz D, et al. Identification of biologic markers of the premature rupture of fetal membranes: proteomic approach. Proteomics 2003;3(8):1521\u20135.","journal-title":"Proteomics"},{"issue":"8","key":"11_CR24","doi-asserted-by":"publisher","first-page":"7080","DOI":"10.1074\/jbc.M409841200","volume":"280","author":"EM Gonzalez","year":"2005","unstructured":"Gonzalez EM, Reed CC, Bix G, et al. BMP-1\/Tolloid-like metalloproteases process endorepellin, the angiostatic C-terminal fragment of perlecan. J Biol Chem 2005;280(8):7080\u20137.","journal-title":"J Biol Chem"},{"issue":"2","key":"11_CR25","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","volume":"88","author":"MS O\u2019Reilly","year":"1997","unstructured":"O\u2019Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88(2):277\u201385.","journal-title":"Cell"},{"issue":"1","key":"11_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1215\/15228517-4-1-1","volume":"4","author":"DR Sorensen","year":"2002","unstructured":"Sorensen DR, Read TA, Porwol T, et al. Endostatin reduces vascularization, blood flow, and growth in a rat gliosarcoma. Neuro-oncol 2002;4(1):1\u20138.","journal-title":"Neuro-oncol"},{"issue":"22","key":"11_CR27","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.3748\/wjg.v10.i22.3361","volume":"10","author":"YH Jia","year":"2004","unstructured":"Jia YH, Dong XS, Wang XS. Effects of endostatin on expression of vascular endothelial growth factor and its receptors and neovascularization in colonic carcinoma implanted in nude mice. World J Gastroenterol 2004;10(22):3361\u20134.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"11_CR28","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1158\/1535-7163.MCT-05-0348","volume":"5","author":"XP Li","year":"2006","unstructured":"Li XP, Li CY, Li X, et al. Inhibition of human nasopharyngeal carcinoma growth and metastasis in mice by adenovirus-associated virus-mediated expression of human endostatin. Mol Cancer Ther 2006;5(5):1290\u20138.","journal-title":"Mol Cancer Ther"},{"issue":"7","key":"11_CR29","first-page":"1944","volume":"62","author":"J Dixelius","year":"2002","unstructured":"Dixelius J, Cross M, Matsumoto T, Sasaki T, Timpl R, Claesson-Welsh L. Endostatin regulates endothelial cell adhesion and cytoskeletal organization. Cancer Res 2002;62(7):1944\u20137.","journal-title":"Cancer Res"},{"issue":"17","key":"11_CR30","doi-asserted-by":"publisher","first-page":"11721","DOI":"10.1074\/jbc.274.17.11721","volume":"274","author":"M Dhanabal","year":"1999","unstructured":"Dhanabal M, Ramchandran R, Waterman MJ, et al. Endostatin induces endothelial cell apoptosis. J Biol Chem 1999; 274(17):11721\u20136.","journal-title":"J Biol Chem"},{"issue":"19","key":"11_CR31","doi-asserted-by":"publisher","first-page":"16464","DOI":"10.1074\/jbc.M112274200","volume":"277","author":"J Hanai","year":"2002","unstructured":"Hanai J, Dhanabal M, Karumanchi SA, et al. Endostatin causes G1 arrest of endothelial cells through inhibition of cyclin D1. J Biol Chem 2002;277(19):16464\u20139.","journal-title":"J Biol Chem"},{"issue":"31","key":"11_CR32","doi-asserted-by":"publisher","first-page":"27872","DOI":"10.1074\/jbc.M202771200","volume":"277","author":"YM Kim","year":"2002","unstructured":"Kim YM, Hwang S, Kim YM, et al. Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR\/Flk-1. J Biol Chem 2002;277(31):27872\u20139.","journal-title":"J Biol Chem"},{"issue":"5 Pt 1","key":"11_CR33","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1006\/mthe.2002.0590","volume":"5","author":"G Yin","year":"2002","unstructured":"Yin G, Liu W, An P, et al. Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis. Mol Ther 2002;5(5 Pt 1):547\u201354.","journal-title":"Mol Ther"},{"issue":"6","key":"11_CR34","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1096\/fj.99-1083com","volume":"15","author":"M Shichiri","year":"2001","unstructured":"Shichiri M, Hirata Y. Antiangiogenesis signals by endostatin. Faseb J 2001;15(6):1044\u201353.","journal-title":"Faseb J"},{"issue":"3","key":"11_CR35","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1073\/pnas.031564998","volume":"98","author":"M Rehn","year":"2001","unstructured":"Rehn M, Veikkola T, Kukk-Valdre E, et al. Interaction of endostatin with integrins implicated in angiogenesis. Proc Natl Acad Sci USA 2001;98(3):1024\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"11_CR36","doi-asserted-by":"publisher","first-page":"4766","DOI":"10.1073\/pnas.0730882100","volume":"100","author":"A Sudhakar","year":"2003","unstructured":"Sudhakar A, Sugimoto H, Yang C, Lively J, Zeisberg M, Kalluri R. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. Proc Natl Acad Sci USA 2003;100(8):4766\u201371.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"19","key":"11_CR37","first-page":"5580","volume":"62","author":"SA Wickstrom","year":"2002","unstructured":"Wickstrom SA, Alitalo K, Keski-Oja J. Endostatin associates with integrin alpha5beta1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer Res 2002;62(19):5580\u20139.","journal-title":"Cancer Res"},{"issue":"1\u20133","key":"11_CR38","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0014-5793(03)00003-6","volume":"536","author":"K Eriksson","year":"2003","unstructured":"Eriksson K, Magnusson P, Dixelius J, Claesson-Welsh L, Cross MJ. Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways. FEBS Lett 2003;536(1\u20133):19\u201324.","journal-title":"FEBS Lett"},{"issue":"4","key":"11_CR39","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S1097-2765(01)00225-8","volume":"7","author":"SA Karumanchi","year":"2001","unstructured":"Karumanchi SA, Jha V, Ramchandran R, et al. Cell surface glypicans are low-affinity endostatin receptors. Mol Cell 2001;7(4):811\u201322.","journal-title":"Mol Cell"},{"issue":"23","key":"11_CR40","doi-asserted-by":"publisher","first-page":"6303","DOI":"10.1093\/emboj\/cdf638","volume":"21","author":"J Kreuger","year":"2002","unstructured":"Kreuger J, Matsumoto T, Vanwildemeersch M, et al. Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function. Embo J 2002;21(23):6303\u201311.","journal-title":"Embo J"},{"issue":"3","key":"11_CR41","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.bbrc.2005.06.011","volume":"333","author":"RC Reis","year":"2005","unstructured":"Reis RC, Schuppan D, Barreto AC, et al. Endostatin competes with bFGF for binding to heparin-like glycosaminoglycans. Biochem Biophys Res Commun 2005;333(3):976\u201383.","journal-title":"Biochem Biophys Res Commun"},{"issue":"19","key":"11_CR42","doi-asserted-by":"publisher","first-page":"20178","DOI":"10.1074\/jbc.M312921200","volume":"279","author":"SA Wickstrom","year":"2004","unstructured":"Wickstrom SA, Alitalo K, Keski-Oja J. An endostatin-derived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial cells. J Biol Chem 2004;279(19):20178\u201385.","journal-title":"J Biol Chem"},{"issue":"19","key":"11_CR43","first-page":"5410","volume":"60","author":"YM Kim","year":"2000","unstructured":"Kim YM, Jang JW, Lee OH, et al. Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase. Cancer Res 2000;60(19):5410\u20133.","journal-title":"Cancer Res"},{"issue":"1\u20133","key":"11_CR44","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0014-5793(02)02742-4","volume":"519","author":"SJ Lee","year":"2002","unstructured":"Lee SJ, Jang JW, Kim YM, et al. Endostatin binds to the catalytic domain of matrix metalloproteinase-2. FEBS Lett 2002;519(1\u20133): 147\u201352.","journal-title":"FEBS Lett"},{"issue":"25","key":"11_CR45","doi-asserted-by":"publisher","first-page":"22404","DOI":"10.1074\/jbc.M210325200","volume":"278","author":"P Nyberg","year":"2003","unstructured":"Nyberg P, Heikkila P, Sorsa T, et al. Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13. J Biol Chem 2003;278(25):22404\u201311.","journal-title":"J Biol Chem"},{"issue":"17","key":"11_CR46","first-page":"6511","volume":"61","author":"SA Wickstrom","year":"2001","unstructured":"Wickstrom SA, Veikkola T, Rehn M, Pihlajaniemi T, Alitalo K, Keski-Oja J. Endostatin-induced modulation of plasminogen activation with concomitant loss of focal adhesions and actin stress fibers in cultured human endothelial cells. Cancer Res 2001;61(17):6511\u20136.","journal-title":"Cancer Res"},{"issue":"3","key":"11_CR47","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0014-5793(00)02249-3","volume":"486","author":"M Ferreras","year":"2000","unstructured":"Ferreras M, Felbor U, Lenhard T, Olsen BR, Delaisse J. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett 2000;486(3):247\u201351.","journal-title":"FEBS Lett"},{"issue":"8","key":"11_CR48","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1073\/pnas.0500180102","volume":"102","author":"M Sund","year":"2005","unstructured":"Sund M, Hamano Y, Sugimoto H, et al. Function of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors. Proc Natl Acad Sci USA 2005;102(8):2934\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"11_CR49","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/sj.ejhg.5200721","volume":"9","author":"TS \u2003Zorick","year":"2001","unstructured":"Zorick TS, Mustacchi Z, Bando SY, et al. High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumours. Eur J Hum Genet 2001;9(11):811\u20134.","journal-title":"Eur J Hum Genet"},{"key":"11_CR50","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1101\/sqb.2002.67.255","volume":"67","author":"R Kalluri","year":"2002","unstructured":"Kalluri R. Discovery of type IV collagen non-collagenous domains as novel integrin ligands and endogenous inhibitors of angiogenesis. Cold Spring Harb Symp Quant Biol 2002;67: 255\u201366.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"6","key":"11_CR51","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1089\/104454904323145254","volume":"23","author":"AR Albig","year":"2004","unstructured":"Albig AR, Schiemann WP. Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells. DNA Cell Biol 2004;23(6):367\u201379.","journal-title":"DNA Cell Biol"},{"issue":"11","key":"11_CR52","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1161\/01.RES.0000149568.85071.FB","volume":"95","author":"AD Nguyen","year":"2004","unstructured":"Nguyen AD, Itoh S, Jeney V, et al. Fibulin-5 is a novel binding protein for extracellular superoxide dismutase. Circ Res 2004;95(11):1067\u201374.","journal-title":"Circ Res"},{"issue":"12","key":"11_CR53","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1002\/jgm.626","volume":"6","author":"CH Lee","year":"2004","unstructured":"Lee CH, Wu CL, Shiau AL. Endostatin gene therapy delivered by Salmonella choleraesuis in murine tumor models. J Gene Med 2004;6(12):1382\u201393.","journal-title":"J Gene Med"},{"issue":"6","key":"11_CR54","first-page":"1729","volume":"151","author":"JC Myers","year":"1997","unstructured":"Myers JC, Li D, Bageris A, Abraham V, Dion AS, Amenta PS. Biochemical and immunohistochemical characterization of human type XIX defines a novel class of basement membrane zone collagens. Am J Pathol 1997;151(6):1729\u201340.","journal-title":"Am J Pathol"},{"issue":"27","key":"11_CR55","doi-asserted-by":"publisher","first-page":"17104","DOI":"10.1074\/jbc.272.27.17104","volume":"272","author":"H Sumiyoshi","year":"1997","unstructured":"Sumiyoshi H, Inoguchi K, Khaleduzzaman M, Ninomiya Y, Yoshioka H. Ubiquitous expression of the alpha1(XIX) collagen gene (Col19a1) during mouse embryogenesis becomes restricted to a few tissues in the adult organism. J Biol Chem 1997;272(27):17104\u201311.","journal-title":"J Biol Chem"},{"issue":"2","key":"11_CR56","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1158\/1535-7163.MCT-06-0207","volume":"6","author":"L Ramont","year":"2007","unstructured":"Ramont L, Brassart-Pasco S, Thevenard J, et al. The NC1 domain of type XIX collagen inhibits in vivo melanoma growth. Mol Cancer Ther 2007;6(2):506\u201314.","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"11_CR57","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1006\/bbrc.1999.0248","volume":"255","author":"R Ramchandran","year":"1999","unstructured":"Ramchandran R, Dhanabal M, Volk R, et al. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. Biochem Biophys Res Commun 1999;255(3):735\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"11_CR58","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1006\/jmbi.2000.3996","volume":"301","author":"T Sasaki","year":"2000","unstructured":"Sasaki T, Larsson H, Tisi D, Claesson-Welsh L, Hohenester E, Timpl R. Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J Mol Biol 2000;301(5):1179\u201390.","journal-title":"J Mol Biol"},{"issue":"41","key":"11_CR59","doi-asserted-by":"crossref","first-page":"25475","DOI":"10.1016\/S0021-9258(18)47275-4","volume":"269","author":"JC Monboisse","year":"1994","unstructured":"Monboisse JC, Garnotel R, Bellon G, et al. The alpha 3 chain of type IV collagen prevents activation of human polymorphonuclear leukocytes. J Biol Chem 1994;269(41):25475\u201382.","journal-title":"J Biol Chem"},{"issue":"33","key":"11_CR60","doi-asserted-by":"publisher","first-page":"20395","DOI":"10.1074\/jbc.272.33.20395","volume":"272","author":"J Han","year":"1997","unstructured":"Han J, Ohno N, Pasco S, Monboisse JC, Borel JP, Kefalides NA. A cell binding domain from the alpha3 chain of type IV collagen inhibits proliferation of melanoma cells. J Biol Chem 1997;272(33):20395\u2013401.","journal-title":"J Biol Chem"},{"issue":"28","key":"11_CR61","doi-asserted-by":"publisher","first-page":"21340","DOI":"10.1074\/jbc.M001956200","volume":"275","author":"Y Maeshima","year":"2000","unstructured":"Maeshima Y, Colorado PC, Torre A, et al. Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem 2000;275(28):21340\u20138.","journal-title":"J Biol Chem"},{"issue":"3","key":"11_CR62","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1074\/jbc.M307736200","volume":"279","author":"N Floquet","year":"2004","unstructured":"Floquet N, Pasco S, Ramont L, et al. The antitumor properties of the alpha3(IV)-(185\u2013203) peptide from the NC1 domain of type IV collagen (tumstatin) are conformation-dependent. J Biol Chem 2004;279(3):2091\u2013100.","journal-title":"J Biol Chem"},{"issue":"18","key":"11_CR63","first-page":"4584","volume":"59","author":"TA Shahan","year":"1999","unstructured":"Shahan TA, Ziaie Z, Pasco S, et al. Identification of CD47\/ integrin-associated protein and alpha(v) beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells. Cancer Res 1999;59(18):4584\u201390.","journal-title":"Cancer Res"},{"issue":"34","key":"11_CR64","doi-asserted-by":"publisher","first-page":"31959","DOI":"10.1074\/jbc.M103024200","volume":"276","author":"Y Maeshima","year":"2001","unstructured":"Maeshima Y, Yerramalla UL, Dhanabal M, et al. Extracellular matrix-derived peptide binds to alpha(v) beta(3) integrin and inhibits angiogenesis. J Biol Chem 2001;276(34):31959\u201368.","journal-title":"J Biol Chem"},{"issue":"31","key":"11_CR65","doi-asserted-by":"publisher","first-page":"23745","DOI":"10.1074\/jbc.C000186200","volume":"275","author":"Y Maeshima","year":"2000","unstructured":"Maeshima Y, Colorado PC, Kalluri R. Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties. J Biol Chem 2000;275(31):23745\u201350.","journal-title":"J Biol Chem"},{"issue":"5552","key":"11_CR66","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1126\/science.1065298","volume":"295","author":"Y Maeshima","year":"2002","unstructured":"Maeshima Y, Sudhakar A, Lively JC, et al. Tumstatin, an endothelial cell-specific inhibitor of protein synthesis. Science 2002;295(5552):140\u20133.","journal-title":"Science"},{"issue":"11","key":"11_CR67","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1096\/fj.02-0691fje","volume":"17","author":"H Hutchings","year":"2003","unstructured":"Hutchings H, Ortega N, Plouet J. Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation. Faseb J 2003;17(11):1520\u20132.","journal-title":"Faseb J"},{"issue":"6","key":"11_CR68","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1535-6108(03)00133-8","volume":"3","author":"Y Hamano","year":"2003","unstructured":"Hamano Y, Zeisberg M, Sugimoto H, et al. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. Cancer Cell 2003;3(6):589\u2013601.","journal-title":"Cancer Cell"},{"issue":"23","key":"11_CR69","doi-asserted-by":"publisher","first-page":"11331","DOI":"10.1158\/0008-5472.CAN-06-1540","volume":"66","author":"T Kawaguchi","year":"2006","unstructured":"Kawaguchi T, Yamashita Y, Kanamori M, et al. The PTEN\/Akt Pathway Dictates the Direct {alpha}V{beta}3-Dependent Growth-Inhibitory Action of an Active Fragment of Tumstatin in Glioma Cells In vitro and In vivo. Cancer Res 2006;66 (23):11331\u201340.","journal-title":"Cancer Res"},{"issue":"5","key":"11_CR70","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0955-0674(00)00248-9","volume":"13","author":"LJ McCawley","year":"2001","unstructured":"McCawley LJ, Matrisian LM. Matrix metalloproteinases: they\u2019re not just for matrix anymore! Curr Opin Cell Biol 2001;13(5):534\u201340.","journal-title":"Curr Opin Cell Biol"},{"issue":"2","key":"11_CR71","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1582-4934.2005.tb00355.x","volume":"9","author":"JE Rundhaug","year":"2005","unstructured":"Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 2005;9(2):267\u201385.","journal-title":"J Cell Mol Med"},{"issue":"5789","key":"11_CR72","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1126\/science.1126391","volume":"313","author":"JG Teodoro","year":"2006","unstructured":"Teodoro JG, Parker AE, Zhu X, Green MR. p53-mediated inhibition of angiogenesis through up-regulation of a collagen prolyl hydroxylase. Science 2006;313(5789):968\u201371.","journal-title":"Science"},{"issue":"7","key":"11_CR73","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.2337\/diabetes.53.7.1831","volume":"53","author":"Y Yamamoto","year":"2004","unstructured":"Yamamoto Y, Maeshima Y, Kitayama H, et al. Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes 2004;53(7):1831\u201340.","journal-title":"Diabetes"},{"issue":"10","key":"11_CR74","doi-asserted-by":"publisher","first-page":"2891","DOI":"10.2337\/diabetes.54.10.2891","volume":"54","author":"K Ichinose","year":"2005","unstructured":"Ichinose K, Maeshima Y, Yamamoto Y, et al. Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model. Diabetes 2005;54(10):2891\u2013903.","journal-title":"Diabetes"},{"issue":"1","key":"11_CR75","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-9440(10)61697-5","volume":"159","author":"K Mori","year":"2001","unstructured":"Mori K, Ando A, Gehlbach P, et al. Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin. Am J Pathol 2001;159(1):313\u201320.","journal-title":"Am J Pathol"},{"issue":"5","key":"11_CR76","first-page":"890","volume":"29","author":"H Matsuno","year":"2002","unstructured":"Matsuno H, Yudoh K, Uzuki M, et al. Treatment with the angiogenesis inhibitor endostatin: a novel therapy in rheumatoid arthritis. J Rheumatol 2002;29(5):890\u20135.","journal-title":"J Rheumatol"},{"issue":"22","key":"11_CR77","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.1200\/JCO.2006.05.6762","volume":"24","author":"MH Kulke","year":"2006","unstructured":"Kulke MH, Bergsland EK, Ryan DP, et al. Phase II Study of Recombinant Human Endostatin in Patients With Advanced Neuroendocrine Tumors. J Clin Oncol 2006;24(22):3555\u201361.","journal-title":"J Clin Oncol"},{"issue":"2","key":"11_CR78","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3748\/wjg.v9.i2.262","volume":"9","author":"X Li","year":"2003","unstructured":"Li X, Fu GF, Fan YR, et al. Potent inhibition of angiogenesis and liver tumor growth by administration of an aerosol containing a transferrin-liposome-endostatin complex. World J Gastroenterol 2003;9(2):262\u20136.","journal-title":"World J Gastroenterol"},{"issue":"8","key":"11_CR79","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1158\/0008-5472.CAN-05-3297","volume":"66","author":"IV Subramanian","year":"2006","unstructured":"Subramanian IV, Bui Nguyen TM, Truskinovsky AM, Tolar J, Blazar BR, Ramakrishnan S. Adeno-associated virus-mediated delivery of a mutant endostatin in combination with carboplatin treatment inhibits orthotopic growth of ovarian cancer and improves long-term survival. Cancer Res 2006;66(8):4319\u201328.","journal-title":"Cancer Res"},{"issue":"3","key":"11_CR80","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ijrobp.2006.10.030","volume":"67","author":"S Itasaka","year":"2007","unstructured":"Itasaka S, Komaki R, Herbst RS, et al. Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice. Int J Radiat Oncol Biol Phys 2007;67(3):870\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"11_CR81","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/sj.cgt.7701003","volume":"14","author":"YF Xu","year":"2007","unstructured":"Xu YF, Zhu LP, Hu B, et al. A new expression plasmid in Bifidobacterium longum as a delivery system of endostatin for cancer gene therapy. Cancer Gene Ther 2007;14(2):151\u20137.","journal-title":"Cancer Gene Ther"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-0-387-71518-6_11.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T23:38:44Z","timestamp":1631317124000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-0-387-71518-6_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"ISBN":["9780387715179","9780387715186"],"references-count":81,"URL":"https:\/\/doi.org\/10.1007\/978-0-387-71518-6_11","relation":{},"subject":[],"published":{"date-parts":[[2008]]}}}